Misoprostol Effect on Second Trimester Abortion Blood Loss (MORE STABL)
Blood Loss, Surgical, Second Trimester Abortion
About this trial
This is an interventional prevention trial for Blood Loss, Surgical
Eligibility Criteria
Inclusion Criteria: Pregnant people, 18 years of age or older; intrauterine pregnancy between 18/0-23/6 weeks of gestational age (by ultrasound dating performed prior to same day of enrollment visit) consented for an induced abortion; English or Spanish speaking, able to consent for a research study, literate in English or Spanish. Exclusion Criteria: known coagulopathy, suspected morbidly adherent placenta spectrum, multiple gestation, current infection, ruptured membranes, or fetal demise at time of enrollment.
Sites / Locations
- Stanford University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Misoprostol 400mcg buccal
Placebo
Participants will take 400mcg buccal misoprostol 2-3 hours prior to their procedure
Participants will take a placebo bucally 2-3 hours prior to their procedure